The FDA has granted 510(k) clearance for EndoGastric Solutions’ EsophyX Z device. 1. The EsophyX Z device is the next-generation version of the EsophyX device. 2. EsophyX Z allows physicians to ...
Patients either underwent the procedure with the EsophyX device or received high-dose proton-pump inhibitor therapy. After six months the PPI control group received the TIF procedure. 2. The study ...
(and 43 states providing coverage). “The robust body of clinical evidence which supports the TIF 2.0 or discontinue PPI use and want a less invasive procedure than traditional surgery has access to ...
Redmond, Wash.-based EndoGastric Solutions will pay up to $5.25 million to settle allegations that it violated the False Claims Act by inappropriately advising healthcare providers when billing ...
SOUTH JORDAN, Utah, March 27, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (MMSI), a global leader of healthcare technology, announced today that the American Society for Gastrointestinal ...
Merit Medical Systems Inc. acquired the Esophyx Z+ device from Endogastric Solutions Inc. for $105 million in cash, adding a durable, non-pharmacological treatment for gastroesophageal reflux disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results